Sanofi reaping rewards of Emerging Markets focus
This article was originally published in OTC Bulletin & The Rose Sheet
Having concentrated resources in a number of “key” countries including Brazil, Mexico and Russia, Sanofi Consumer Healthcare is enjoying a “strong” growth trajectory in its Emerging Markets, the French pharmaceuticals giant told OTC bulletin.
You may also be interested in...
GSK is looking to close out 2018 strongly as it prepares to launch its Consumer Health JV with Pfizer, while Bayer will be glad to see the back of a tough year. Elsewhere, RB is preparing for life after Rakesh Kapoor and Sanofi is ramping up its push into digital health.
More Encouraging Real World Data From UK – But Can It Turn Around European Sentiment On AZ COVID-19 Vaccine?
Another real-world study from the UK’s rapid vaccine rollout provides evidence that Pfizer’s vaccine saves lives, with the AZ shot matching it on cutting hospitalizations.
Arena's Phase IIb CAPTIVATE trial assessing investigational olorinab in IBS missed its primary endpoint.